These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29354529)

  • 1. Pharmacist-led implementation of a vancomycin guideline across medical and surgical units: impact on clinical behavior and therapeutic drug monitoring outcomes.
    Phillips CJ; Gordon DL
    Integr Pharm Res Pract; 2015; 4():145-152. PubMed ID: 29354529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained improvement in vancomycin dosing and monitoring post-implementation of guidelines: Results of a three-year follow-up after a multifaceted intervention in an Australian teaching hospital.
    Phillips CJ; McKinnon RA; Woodman RJ; Gordon DL
    J Infect Chemother; 2018 Feb; 24(2):103-109. PubMed ID: 29037461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
    Joseph K; Ramireddy K; Madison G; Turco T; Lui M
    J Clin Pharm Ther; 2021 Aug; 46(4):1103-1108. PubMed ID: 33768555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions Targeting the Prescribing and Monitoring of Vancomycin for Hospitalized Patients: A Systematic Review Protocol.
    Phillips CJ; Wisdom AJ; McKinnon RA; Woodman RJ; Gordon DL
    Infect Dis Ther; 2017 Dec; 6(4):557-563. PubMed ID: 29080067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin Prescribing Practices and Therapeutic Drug Monitoring for Critically Ill Neonatal and Pediatric Patients: A Survey of Physicians and Pharmacists in Hong Kong.
    Chow TCH; Li JYS; Wong JCL; Poon FMH; Lam HS; Lam TT; Lee CP; Ewig CL; Cheung YT
    Front Pediatr; 2020; 8():538298. PubMed ID: 33330263
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Implementation of a Novel Web-Based E-Learning Tool for Education of Health Professionals on the Antibiotic Vancomycin.
    Bond SE; Crowther SP; Adhikari S; Chubaty AJ; Yu P; Borchard JP; Boutlis CS; Yeo WW; Miyakis S
    J Med Internet Res; 2017 Mar; 19(3):e93. PubMed ID: 28360025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM
    Pharmacotherapy; 2020 Apr; 40(4):363-367. PubMed ID: 32227354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pre-postintervention study to evaluate the impact of dose calculators on the accuracy of gentamicin and vancomycin initial doses.
    Hamad A; Cavell G; Hinton J; Wade P; Whittlesea C
    BMJ Open; 2015 Jun; 5(6):e006610. PubMed ID: 26044758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
    Masuda N; Maiguma T; Komoto A; Haruki Y; Sugiyama T; Kondo S; Teshima D
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.
    Frymoyer A; Guglielmo BJ; Wilson SD; Scarpace SB; Benet LZ; Hersh AL
    Pharmacotherapy; 2011 Sep; 31(9):871-6. PubMed ID: 21923588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant
    Hirano R; Sakamoto Y; Kitazawa J; Yamamoto S; Tachibana N
    Infect Drug Resist; 2016; 9():243-252. PubMed ID: 27789965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
    Reilly AM; Ding MX; Rower JE; Kiser TH
    J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Hall RG; Blaszczyk AT; Thompson KA; Brouse SD; Giuliano CA; Frei CR; Forcade NA; Mortensen EM; Bell T; Bedimo RJ; Alvarez CA
    J Clin Pharm Ther; 2014 Dec; 39(6):653-7. PubMed ID: 25200273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
    Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
    J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Canadian perspective on the revised 2020 ASHP-IDSA-PIDS-SIDP guidelines for vancomycin AUC-based therapeutic drug monitoring for serious MRSA infections.
    Stewart JJ; Jorgensen SC; Dresser L; Lau TT; Gin A; Thirion DJ; Nishi C; Dalton B
    J Assoc Med Microbiol Infect Dis Can; 2021 Mar; 6(1):3-9. PubMed ID: 36340210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting vancomycin therapy outcomes in hemodialysis outpatients and the role of the nephrology stewardship pharmacist.
    El Nekidy WS; El-Masri MM; Ghazi IM; Soong D
    Hemodial Int; 2019 Oct; 23(4):449-457. PubMed ID: 31361089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.
    Kullar R; Davis SL; Taylor TN; Kaye KS; Rybak MJ
    Pharmacotherapy; 2012 Mar; 32(3):195-201. PubMed ID: 22392452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.
    Davis SL; Scheetz MH; Bosso JA; Goff DA; Rybak MJ
    Pharmacotherapy; 2013 Dec; 33(12):1256-63. PubMed ID: 23897602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.